Provided by Tiger Fintech (Singapore) Pte. Ltd.

Revive Therapeutics Ltd.

0.0192
-0.0030-13.51%
Volume:255.79K
Turnover:4.95K
Market Cap:8.04M
PE:-2.14
High:0.0205
Open:0.0205
Low:0.0181
Close:0.0222
Loading ...

Company Profile

Company Name:
Revive Therapeutics Ltd.
Exchange:
PINK
Establishment Date:
- -
Employees:
2
Office Location:
The Canadian Venture Building,82 Richmond Street East,Toronto,Ontario,Canada
Zip Code:
M5C 1P1
Fax:
905-248-3355
Introduction:
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is based in Toronto, Canada.